Production (Stage)
Guardant Health, Inc.
GH
$38.00
$0.952.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.28% | -3.02% | -4.99% | 10.75% | 38.52% |
| Total Depreciation and Amortization | -2.09% | -1.36% | -0.24% | -0.83% | -1.44% |
| Total Amortization of Deferred Charges | -- | 0.16% | 0.00% | -- | -- |
| Total Other Non-Cash Items | 19.22% | -33.70% | 12.92% | -22.79% | 102.64% |
| Change in Net Operating Assets | -724.08% | 76.78% | 77.28% | -782.57% | -87.74% |
| Cash from Operations | 2.83% | -26.35% | 45.68% | -210.40% | 61.53% |
| Capital Expenditure | 76.38% | -349.51% | 17.29% | 26.78% | -70.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 945.14% | 110.12% | -- | -100.00% | -94.76% |
| Cash from Investing | 2,776.20% | 103.57% | -5,707.11% | -118.09% | -95.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.73% | 25,045.00% | -99.79% | 4,395.77% | -99.77% |
| Repurchase of Common Stock | -654.17% | -179.16% | 11.30% | -109.84% | 49.95% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20,677.97% | 290.32% | 92.92% | -270.43% | 148.04% |
| Cash from Financing | -2,177.68% | -1.73% | -148.91% | 649.16% | -101.19% |
| Foreign Exchange rate Adjustments | 145.60% | -189.21% | 327.00% | 26.45% | -210.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 397.03% | 83.10% | -268.94% | -2,022.30% | -100.66% |